Renal thrombotic microangiopathy is associated with poor renal survival in children with immunoglobulin A nephropathy.

This study examined a serious kidney condition in children called IgA nephropathy (IgAN), which occurs when an immune protein builds up in the kidneys. Researchers specifically looked at cases where children also developed blood clots in tiny kidney vessels, a complication called renal thrombotic microangiopathy (rTMA). The study included 69 children with IgAN, comparing 23 who had rTMA with 46 who did not.

Researchers found that children with both IgAN and rTMA had more severe kidney disease. These children showed worse clinical symptoms and more kidney damage visible under the microscope. Three specific findings increased the risk of developing rTMA: certain types of cell overgrowth in the kidneys (E1), endocapillary proliferation, and C3 protein deposits. Most importantly, children with rTMA had much poorer kidney survival rates, meaning they were more likely to progress to end-stage kidney disease requiring dialysis or transplant.

This study does not involve acupuncture or complementary medicine approaches. It is a conventional medical study examining kidney disease progression in pediatric patients. For families dealing with childhood kidney disease, this research helps doctors identify which children are at highest risk for kidney failure. The presence of blood clots in kidney vessels appears to be a warning sign that the disease may progress more rapidly. If you are considering complementary approaches like acupuncture alongside conventional treatment for any serious medical condition, it is essential to work with a qualified, licensed acupuncturist who can coordinate care with your medical team.

This retrospective study analyzed 69 pediatric IgAN patients (23 with rTMA, 46 without) matched for epidemiological and pathological characteristics. IgAN patients with concurrent rTMA demonstrated significantly more severe clinical and pathological manifestations. Logistic regression identified three independent risk factors for rTMA development: hypercellularity E1 (HR: 0.805, 95% CI: 0.763-1.452, P=0.016), endocapillary proliferation (HR: 1.214, 95% CI: 0.093-4.815, P=0.025), and C3 staining (HR: 7.554, 95% CI: 2.563-15.729, P=0.037). Renal survival was significantly worse in the rTMA group (χ²=18.467, P=0.000). Cox regression confirmed rTMA as an independent risk factor for ESRD progression (HR: 8.918, 95% CI: 1.032-16.754, P=0.041), alongside E1 and C3 deposition. This study does not involve acupuncture or complementary medicine but provides important prognostic information for conventional nephrology management.